Bill
LD 180
Overview: LD 180, "An Act Regarding The Interactions Of Pharmacy Benefits Managers And So-Called 340B Entities And Reimbursements By Pharmacy Benefits Managers To Pharmacies", was
Overview: LD 180, "An Act Regarding The Interactions Of Pharmacy Benefits Managers And So-Called 340B Entities And Reimbursements By Pharmacy Benefits Managers To Pharmacies", was signed into law.
Purpose and Intent: The bill aims to regulate the interactions between pharmacy benefits managers (PBMs) and 340B entities, which are healthcare providers that serve low-income and uninsured patients. The legislation seeks to ensure fair reimbursement practices and transparency in the PBM-340B entity relationship.
Key Provisions:
- Prohibits PBMs from discriminating against or imposing different terms and conditions on 340B entities compared to other pharmacies
- Requires PBMs to report the aggregate amount of 340B drug reimbursements and the aggregate amount of 340B drug claims processed
- Mandates that PBMs reimburse 340B entities at rates that are no less than the rates paid to other network pharmacies for the same drug
Affected Parties and Impacts: The bill primarily affects 340B entities, such as community health centers and hospitals that serve low-income populations, as well as the PBMs that manage their prescription drug benefits. It aims to protect 340B entities from unfair PBM practices and ensure they receive appropriate reimbursement for the drugs they provide.
Procedural and Timeline Considerations: LD 180 was signed into law, indicating it has completed the legislative process and is now in effect.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
